Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

iHuman (IH) EBIT (2019 - 2025)

Historic EBIT for iHuman (IH) over the last 7 years, with Q3 2025 value amounting to $16.7 million.

  • iHuman's EBIT fell 1947.53% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year decrease of 8144.21%. This contributed to the annual value of $10.0 million for FY2024, which is 5575.0% down from last year.
  • As of Q3 2025, iHuman's EBIT stood at $16.7 million, which was down 1947.53% from $19.5 million recorded in Q2 2025.
  • In the past 5 years, iHuman's EBIT ranged from a high of $334.6 million in Q4 2023 and a low of -$43.9 million during Q3 2021
  • Over the past 5 years, iHuman's median EBIT value was $19.5 million (recorded in 2025), while the average stood at $34.7 million.
  • In the last 5 years, iHuman's EBIT tumbled by 42395.69% in 2021 and then soared by 75498.26% in 2022.
  • iHuman's EBIT (Quarter) stood at -$10.6 million in 2021, then surged by 470.09% to $39.1 million in 2022, then surged by 754.94% to $334.6 million in 2023, then tumbled by 95.54% to $14.9 million in 2024, then grew by 11.72% to $16.7 million in 2025.
  • Its last three reported values are $16.7 million in Q3 2025, $19.5 million for Q2 2025, and $21.6 million during Q1 2025.